Golimumab [476181-74-5]

TargetMol Chemicals

Golimumab

9

476181-74-5

Antibody

Research Use Only

Golimumab

146.93KD

Golimumab (CNTO-148) is a potent humanized anti-TNFalpha IgG1kappa monoclonal antibody with anti-inflammatory and anticancer activity. It inhibits the production of IL-6 and IL-1beta, induces apoptosis, and can be used to prevent inflammation and destruction of cartilage or bone. This makes Golimumab valuable for studying rheumatoid arthritis and cancer.

3 years

-20°C

12352203